Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nifedipine: two new uses.

C S Conner

    Drug Intelligence & Clinical Pharmacy
    |June 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Nifedipine effectively lowers blood pressure in malignant hypertension and treats Raynaud's phenomenon. This calcium channel blocker offers a safe and convenient option for managing these conditions.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Withered Yang: a review of traditional Chinese medical treatment of male infertility and erectile dysfunction.

    Journal of andrology·2001
    Same author

    Conflicting data in the literature: a true dilemma.

    Drug intelligence & clinical pharmacy·1986
    Same author

    beta-Lactamase inhibitors.

    Drug intelligence & clinical pharmacy·1985
    Same author

    Transdermal nitroglycerin: a reevaluation.

    Drug intelligence & clinical pharmacy·1984
    Same author

    Oral gold in arthritis.

    Drug intelligence & clinical pharmacy·1984
    Same author

    Atracurium and vecuronium: two unique neuromuscular blocking agents.

    Drug intelligence & clinical pharmacy·1984
    Same journal

    Profile of prescription medication in a pediatric population.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    SI units in drug therapeutics.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    Physicians' review of significant interventions by clinical pharmacists in inpatient care.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    Possible interaction of ranitidine with phenytoin.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    Famotidine-associated mental confusion in elderly patients.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    Intravenous self-administration of elemental mercury: efficacy of dimercaprol therapy.

    Drug intelligence & clinical pharmacy·1988
    See all related articles

    Area of Science:

    • Pharmacology
    • Cardiovascular Medicine

    Background:

    • Nifedipine is a calcium channel blocker approved for angina.
    • Its vasodilatory effects suggest broader therapeutic potential.

    Purpose of the Study:

    • To evaluate nifedipine's efficacy in malignant hypertension and Raynaud's phenomenon.
    • To assess its suitability for emergency and office settings.

    Main Methods:

    • Administration of single oral doses (10-20 mg) of nifedipine.
    • Observational studies on patient outcomes for hypertension and Raynaud's phenomenon.

    Main Results:

    • Nifedipine rapidly and smoothly reduced blood pressure in malignant hypertension.
    • The drug demonstrated efficacy in treating Raynaud's phenomenon.

    Conclusions:

    • Nifedipine is a promising treatment for malignant hypertension and Raynaud's phenomenon.
    • It can be administered without continuous patient monitoring.
    • Consider nifedipine as a first-line agent for Raynaud's phenomenon.